Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.
about
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockProcalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Inflammatory mediators in intra-abdominal sepsis or injury - a scoping reviewProcalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unitProcalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysisAME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospitalAntibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission ratesEffectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.Advances in Intra-abdominal Sepsis: What Is New?Using Procalcitonin to Guide Antibiotic Therapy.Biomarker-guided antibiotic therapy-strengths and limitationsProcalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shockProcalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.New approaches to sepsis: molecular diagnostics and biomarkers.Interventions to improve antibiotic prescribing practices for hospital inpatients.Procalcitonin levels associate with severity of Clostridium difficile infectionProcalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shockStop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic durAntibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis.The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesDe-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges.Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosisRole of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapyImplementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaNeutrophil CD64: a diagnostic marker for infection and sepsis.Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.Biomarkers for sepsis: a review with special attention to India.Biomarkers in the diagnosis of aspiration syndromes.Strategies for reduction in duration of antibiotic use in hospitalized patients.Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances.An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients.
P2860
Q24187768-10AA908D-3713-4E6F-A1AA-867927D18BF5Q24198268-12DDE634-3AA3-4B4A-A522-DB7966DC7177Q24200676-65CC4BEB-97BD-4674-892E-EF5F341AB5E6Q24235566-DEA71CB2-72E0-4F8C-B219-4B9A265E2866Q24236108-F7455C70-B9AF-4A5C-990D-9612CE14DC24Q26739860-25035C65-29B8-4A3A-9824-61D8EEFB9B93Q26778888-12084474-804E-4033-B6FB-612627C7D19BQ26798459-7A841029-FB8A-443E-86DE-9D8C6D7D6A93Q27028085-4CD7C1D6-E2DA-409B-9330-8B6ED92CFF4AQ28077765-D91B262D-DFF4-46B7-9482-1575BF6E1C32Q28536492-3C1B4246-C7F3-4EDB-8E61-27B522FA9A02Q30238953-65CA32C2-8F35-46BC-9C45-9C3FCE8B1DBDQ30279142-D3C9B58F-41B2-4D25-8831-69D65C456AA6Q33629591-A764D7EF-C3F7-48E6-8E7A-4B9D9F7D0765Q33747590-528BE65B-3C16-4773-90CC-738A072C6CBFQ33750023-24AFAB6E-0847-4749-B8A1-CCA84BB3144DQ33754533-9D346AE8-1F1F-40D5-85E5-FD0772F759D1Q34026963-7CE27410-B13A-4FDA-A203-43EFA7A4929EQ34027944-30C141E4-C6D0-4CC7-A0C8-AA30749317CFQ34264291-D16944D8-822F-4F6B-95D8-33E9AF2ED52AQ34303687-78853247-5EDB-4001-B666-6443AB10E2F3Q34550823-1C181EB8-0693-43E7-9827-822A949AED85Q34625689-9C9BE973-2935-49FF-A97D-2109CCC414DFQ34645044-897E98DD-58C0-45E2-AF5E-8918AEE874F0Q34670419-FDAE2C8C-C648-4037-A396-4AC742628A45Q35080067-E84008B9-2C28-4449-BB3D-F97E3B423DA2Q35110932-190E4B90-B2F3-47A8-BB20-BBEF1AEA82D1Q35958759-EC88DA08-FEFB-487D-8523-C5C9A8ACE42AQ35986250-808B9F7D-2A2E-4768-B043-77D6A05C9B2BQ36331033-276888D3-8585-4514-9157-1115C16F3399Q36909844-918EBAB7-5E1D-4AF5-9A44-100B276DF522Q37028474-B253D22E-EB57-4ACF-A96E-1ADCE2BA8B20Q37220711-E672C0D3-6715-45EA-9A91-649636B4C244Q37566603-A584B1D8-5517-4A55-8C8A-FAB290AA1084Q37650812-138BB882-7831-47DC-A35A-FE9D1D627B1AQ37688126-E2B9F013-A7E7-4232-B0C1-9D6FEA209DB8Q37724872-B6DA468B-76E8-4BD8-900A-D8C564D62B88Q37867329-E9FB65F9-CCB8-4E9D-91E5-D17D2A78F852Q37981026-BBA934A9-0986-4A09-9A51-F4047F9F2AC9Q38005908-96D85DC0-F305-4117-BB67-02EB64E6B5CB
P2860
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@ast
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@en
type
label
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@ast
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@en
prefLabel
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@ast
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@en
P2093
P1476
Procalcitonin (PCT)-guided alg ...... prospective randomized study.
@en
P2093
A-M Schweiger
M Hochreiter
S Schroeder
T von Spiegel
P2860
P2888
P304
P356
10.1007/S00423-008-0432-1
P407
P577
2008-11-26T00:00:00Z